Public Private Partnerships for Sustainability Autumn Ehnow London, UK January 12, 2012 Health for each woman, access for all women.
Our Business Model requires partnership Partnerships for: 501c3 nonprofit Founding Mission = U.S. Public Sector Provision Commercialization Distribution Provider training Education Developing Country Access
Cross Product & Cross Sector Partnerships: Sustainability built in Social mission partnership with: 1 st Sector = Commercial Corp 2 nd Sector = Government 3 rd Sector = NGO Coordinated efforts from all sectors needed to realize success Supply Public Sector Commercial sales, profit benefit
Creating a new business model CONFIDENTIAL
The Path to Reaching Patients is NOT linear Research & Development Field & Demand testing Product marketing, distribution, access Establish Metrics and Milestones & Adjust
Patient Investing for Patient Care = Trust is key
Bundling for healthcare Value meal example simple, yes; applicable, absolutely Medical Examples - Proven vaccine bundling (mumps, measles, rubella) - Flu cocktails - Multipurpose prevention technologies to be developed!
Bundling for comprehensive women s health Maternal health Family planning HIV/ AIDS Malaria TB New efficiencies realized through sustained partnerships
Partnerships = Innovation We must strive together for more. So, how do we get there?
PPPs: Must Be Powered for Complexity
We must start with our patients PPPs should be formed with all experts involved
Partnership Expertise Must Include Full Spectrum Therapeutic need/unmet medical need Government Research and Development Commercialization Patient education Provider training Access and delivery
USAID Health Policy Project: Funding Gap for Reproductive Health Family Planning Resource Requirements and Funding (2011 US$)
Essential Medicines for MPTs Must Be Coordinated To Name a few: Establish coordination of essential medicines across treatment indications In-country coordination of unified need for the treatments provided in the MPT Hospital use guidelines as 1 st line, 2 nd line therapy must be coordinated
World Health Organization Engagement LOW Maturity Supply Chain Maturity HIGH Maturity Stage 1: Innovator products developed, made available on limited basis to developing countries based on first stringent regulatory authority approvals Stage 2: WHO process for specifications to define products and list of essential medicines begins Market demand created Stage 3: Product classes become feasible; multiple manufacturers; quality becomes inconsistent and needs uniformity. Product Quality testing parameters need to be established. Stage 4: WHO prequalification or stringent regulatory approvals as basis for developing country approvals. Product testing becomes consistent.
Let s Not Retrofit Drugs from the West
What If We Flip This On It s Axis? Start with the customer, our patients LOW Maturity Supply Chain Maturity HIGH Maturity Stage 1: Stage 2: Stage 3: Stage 4: Country level definition of need (essential medicines) and volume requirements Development of medicines that meet the defined need, to stringent regulatory standards Specification of medicine quality agreed upon with manufacturers, WHO, regulatory, governments Product testing becomes consistent. Product classes established immediately to allow multiple manufacturers Government continually updates volume need Medicines available at consistent high quality; Medicines already deemed essential and at predicted volumes
PPPs for MPTs Require: Funding & partners with goal for sustainability Multi-player partners identified with end game in mind = Reaching patients Maturity building for supplies, WHO prequalification & Regulatory Pathway, Essential Medicines Coordinated procurement Provider training Many others!
GAVI Alliance - What can we utilize? Matching funds Market commitment for the products Value PPPs Reaching patients Realize what works for one, may not work for all
PPP Formation PPP formation must be careful and iterative Can One PPP do it all? Perhaps multiple PPPs need to be formed to reach goal Research & Development Field & Demand testing Product marketing, distribution, access
Health for each woman, access for all women. Create flexible partnerships Create new models Ensure sustainability Be Creative; Be Provocative
Thank you!